Literature DB >> 18671075

In vitro evaluation of various antimicrobials against Mycoplasma gallisepticum and Mycoplasma synoviae by the micro-broth method, and comparison with a commercially-prepared test system.

J M Bradbury1, C A Yavari, C J Giles.   

Abstract

The efficacy of danofloxacin, a new quinolone antimicrobial agent, was tested in vitro by the micro-broth method with nine field strains of Mycoplasma gallisepticum (Mg) and eight of M. synoviae (Ms) and comparison was made with oxytetracycline and tylosin tartrate. The virulent S6 strain of Mg was also included for reference. All Mycoplasma strains, including a strain of Mg that was resistant to tylosin tartrate, were susceptible to danofloxacin with minimal inhibitory concentrations ranging from pound 0.008 to 0.5 microg/ml. A commercially produced test system (Sensititre), using micro-plates whose wells were predosed with antimicrobial agents and then dried, was also investigated. Results with the same three antimicrobials were in agreement with those obtained by the micro-broth method. With the exception of the tylosin resistant strain, the Mg strains were more susceptible to erythromycin than the Ms strains. Conversely, Ms strains were susceptible to apramycin, while the Mg strains appeared to be resistant.

Entities:  

Year:  1994        PMID: 18671075     DOI: 10.1080/03079459408418978

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  8 in total

1.  Characterization of in vivo-acquired resistance to macrolides of Mycoplasma gallisepticum strains isolated from poultry.

Authors:  Irena Gerchman; Sharon Levisohn; Inna Mikula; Lucía Manso-Silván; Inna Lysnyansky
Journal:  Vet Res       Date:  2011-08-02       Impact factor: 3.683

2.  Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin.

Authors:  Nan Zhang; Xiaomei Ye; Yuzhi Wu; Zilong Huang; Xiaoyan Gu; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

3.  Antibiotic susceptibility profiles of Mycoplasma synoviae strains originating from Central and Eastern Europe.

Authors:  Zsuzsa Kreizinger; Dénes Grózner; Kinga M Sulyok; Kristin Nilsson; Veronika Hrivnák; Dušan Benčina; Miklós Gyuranecz
Journal:  BMC Vet Res       Date:  2017-11-17       Impact factor: 2.741

4.  Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model.

Authors:  Nan Zhang; Yuzhi Wu; Zilong Huang; Chuanzhen Zhang; Longfei Zhang; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

5.  Evaluation of Minimum Inhibitory Concentrations for 154 Mycoplasma synoviae isolates from Italy collected during 2012-2017.

Authors:  Salvatore Catania; Marco Bottinelli; Alice Fincato; Michele Gastaldelli; Antonio Barberio; Federica Gobbo; Gaddo Vicenzoni
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

6.  The Monitoring of Mycoplasma gallisepticum Minimum Inhibitory Concentrations during the Last Decade (2010-2020) Seems to Reveal a Comeback of Susceptibility to Macrolides, Tiamulin, and Lincomycin.

Authors:  Marco Bottinelli; Michele Gastaldelli; Micaela Picchi; Arianna Dall'Ora; Lorena Cristovao Borges; Ana Sofía Ramírez; Andrea Matucci; Salvatore Catania
Journal:  Antibiotics (Basel)       Date:  2022-07-29

7.  The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum.

Authors:  Nan Zhang; Xiaoyan Gu; Xiaomei Ye; Xun Wu; Bingxu Zhang; Longfei Zhang; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  Front Microbiol       Date:  2016-05-04       Impact factor: 5.640

8.  Pharmacokinetic/Pharmacodynamic Profiles of Tiamulin in an Experimental Intratracheal Infection Model of Mycoplasma gallisepticum.

Authors:  Xia Xiao; Jian Sun; Tao Yang; Xi Fang; Jie Cheng; Yan Q Xiong; Ya-Hong Liu
Journal:  Front Vet Sci       Date:  2016-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.